Topical Sulfamylon cream inhibits DNA and protein synthesis in the skin donor site wound
Authors:
- John P. HeggersJHJohn P. Heggers
- David L. ChinkesDCDavid L. Chinkes
- Steven E. WolfSWSteven E. Wolf
- Hal K. HawkinsHHHal K. Hawkins
- Robert R. WolfeRWRobert R. Wolfe
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The efficacy of 5% Sulfamylon® solution for the treatment of contaminated explanted human meshed skin graftsBurns, 1999
- Topical Sulfamylon* Reduces Engraftment of Cultured Skin Substitutes on Athymic MiceJournal of Burn Care & Rehabilitation, 1999
- Burn Wound Infections: Current StatusWorld Journal of Surgery, 1998
- Cytotoxicity to Human Leukocytes by Topical Antimicrobial Agents Used for Burn CareJournal of Burn Care & Rehabilitation, 1993
- The Cytotoxic Effects of Commonly Used Topical Antimicrobial Agents on Human Fibroblasts and Keratinocytes1991
- Cytotoxicity to cultured human keratinocytes of topical antimicrobial agentsJournal of Surgical Research, 1990
- In vitro toxicity of topical antimicrobial agents to human fibroblastsJournal of Surgical Research, 1989
- Use of 5% Sulfamylon (Mafenide) Solution After Excision and Grafting of BurnsJournal of Burn Care & Rehabilitation, 1988
- EFFECTS OF SILVER NITRATE AND SULFAMYLON ON EPITHELIAL REGENERATIONPlastic and Reconstructive Surgery, 1970
- THE USE OF A TOPICAL SULFONAMIDE IN THE CONTROL OF BURN WOUND SEPSIS1966